Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (201-210 of 287) with videos related to

Pageof 29
Sort By:
Gastroenterology|November 9, 2011
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitisWilliam J Sandborn, Gert van Assche, Walter Reinisch, et al.
Inflammatory Bowel Diseases|February 21, 2012
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel diseaseGeert D'Haens, Marc Ferrante, Severine Vermeire, et al.
Journal of Crohn'S & Colitis|October 6, 2017
Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk ModelPeter Bossuyt, Celine Debeuckelaere, Marc Ferrante, et al.
Inflammatory Bowel Diseases|January 9, 2007
Predictors of early response to infliximab in patients with ulcerative colitisMarc Ferrante, Séverine Vermeire, Konstantinos H Katsanos, et al.
Gastroenterology|April 13, 2005
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trialPaul Rutgeerts, Gert Van Assche, Séverine Vermeire, et al.
Frontiers in Immunology|September 28, 2020
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype EquilibriumBrecht Creyns, Inge Jacobs, Bram Verstockt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2018
No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring SystemPauline Rivière, Séverine Vermeire, Marie Irles-Depe, et al.
Inflammatory Bowel Diseases|March 3, 2010
Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximabZhe Li, Ingrid Arijs, Gert De Hertogh, et al.
Autophagy|November 20, 2013
Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stressEveline Hoefkens, Kris Nys, Jestinah M John, et al.
Gastroenterology|August 12, 2009
Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's diseaseKonstantinos Karmiris, Gilles Paintaud, Maja Noman, et al.
Pageof 29

Showing results (201-210 of 287) with videos related to

Sort By:
Pageof 29
Gastroenterology|November 9, 2011
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitisWilliam J Sandborn, Gert van Assche, Walter Reinisch, et al.
Inflammatory Bowel Diseases|February 21, 2012
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel diseaseGeert D'Haens, Marc Ferrante, Severine Vermeire, et al.
Journal of Crohn'S & Colitis|October 6, 2017
Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk ModelPeter Bossuyt, Celine Debeuckelaere, Marc Ferrante, et al.
Inflammatory Bowel Diseases|January 9, 2007
Predictors of early response to infliximab in patients with ulcerative colitisMarc Ferrante, Séverine Vermeire, Konstantinos H Katsanos, et al.
Gastroenterology|April 13, 2005
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trialPaul Rutgeerts, Gert Van Assche, Séverine Vermeire, et al.
Frontiers in Immunology|September 28, 2020
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype EquilibriumBrecht Creyns, Inge Jacobs, Bram Verstockt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2018
No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring SystemPauline Rivière, Séverine Vermeire, Marie Irles-Depe, et al.
Inflammatory Bowel Diseases|March 3, 2010
Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximabZhe Li, Ingrid Arijs, Gert De Hertogh, et al.
Autophagy|November 20, 2013
Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stressEveline Hoefkens, Kris Nys, Jestinah M John, et al.
Gastroenterology|August 12, 2009
Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's diseaseKonstantinos Karmiris, Gilles Paintaud, Maja Noman, et al.
Pageof 29